title: Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
authors.affiliation: Department of Surgery, University of Kentucky Medical Center, Lexington 40536.
authors.forename: B A
authors.initials: BA
authors.lastname: Lucas
authors.forename: T H
authors.initials: TH
authors.lastname: Waid
authors.forename: J S
authors.initials: JS
authors.lastname: Thompson
authors.forename: S A
authors.initials: SA
authors.lastname: Brown
authors.forename: L C
authors.initials: LC
authors.lastname: Munch
authors.forename: J W
authors.initials: JW
authors.lastname: McKeown
authors.forename: R J
authors.initials: RJ
authors.lastname: Kryscio
authors.forename: R J
authors.initials: RJ
authors.lastname: Prebeck
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000917:Antibody Formation; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection / Q000628:therapy*; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D016019:Survival Analysis; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D003404:Creatinine